444

SCI PHARMTECH INC

No trades
See on Supercharts

4119 fundamentals

SCI PHARMTECH INC financial statements, including revenue, expenses, profit, and loss

The total revenue of 4119 for the last quarter is 291.42 M TWD, and it's 13.02% higher compared to the previous quarter. The net income of Q4 23 is -3.61 M TWD.

Q2 '22
Q3 '22
Q4 '22
Q1 '23
Q2 '23
Q3 '23
Q4 '23
‪0.00‬
Total revenue
Gross profit
Operating income
Pretax income
Net income
Currency: TWD
Q2 '22
Q3 '22
Q4 '22
Q1 '23
Q2 '23
Q3 '23
Q4 '23
TTM
Total revenueYoY growth
Gross profitYoY growth
Pretax incomeYoY growth
Net incomeYoY growth
EBITDAYoY growth
EBITYoY growth